BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9580775)

  • 1. Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia.
    Hamosh A; Maher JF; Bellus GA; Rasmussen SA; Johnston MV
    J Pediatr; 1998 Apr; 132(4):709-13. PubMed ID: 9580775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant.
    Hamosh A; McDonald JW; Valle D; Francomano CA; Niedermeyer E; Johnston MV
    J Pediatr; 1992 Jul; 121(1):131-5. PubMed ID: 1385627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia.
    Wolff JA; Kulovich S; Yu AL; Qiao CN; Nyhan WL
    Am J Dis Child; 1986 Jun; 140(6):596-602. PubMed ID: 3706242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia.
    Zammarchi E; Donati MA; Ciani F; Pasquini E; Pela I; Fiorini P
    Neuropediatrics; 1994 Oct; 25(5):274-6. PubMed ID: 7885541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor.
    Schmitt B; Steinmann B; Gitzelmann R; Thun-Hohenstein L; Mascher H; Dumermuth G
    Neurology; 1993 Feb; 43(2):421-4. PubMed ID: 8437713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia.
    Alemzadeh R; Gammeltoft K; Matteson K
    Pediatrics; 1996 Jun; 97(6 Pt 1):924-6. PubMed ID: 8657542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic trial of NMDA antagonist for a nonketotic hyperglycinemic infant].
    Imai M; Kitajima H; Tokoro T; Kubo M; Maekawa K
    No To Hattatsu; 1995 Jul; 27(4):327-9. PubMed ID: 7612297
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia.
    Bjoraker KJ; Swanson MA; Coughlin CR; Christodoulou J; Tan ES; Fergeson M; Dyack S; Ahmad A; Friederich MW; Spector EB; Creadon-Swindell G; Hodge MA; Gaughan S; Burns C; Van Hove JL
    J Pediatr; 2016 Mar; 170():234-9. PubMed ID: 26749113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical progress of neonatal non-ketotic hyperglycinemia under treatment].
    García-Pérez A; Martínez-Granero MA; Martín-Ancel AM; Bonet-Serra B; García-Muñoz MJ; García-Segura JM; Viaño J; Lama-More RA
    Rev Neurol; 2004 Oct 16-31; 39(8):727-30. PubMed ID: 15514900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan.
    Chien YH; Hsu CC; Huang A; Chou SP; Lu FL; Lee WT; Hwu WL
    J Child Neurol; 2004 Jan; 19(1):39-42. PubMed ID: 15032382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextromethorphan in infantile nonketotic hyperglycinemia.
    Schmitt B; Steinmann B
    J Pediatr; 1993 Feb; 122(2):324-5. PubMed ID: 8429455
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic clues and outcome of early treatment of nonketotic hyperglycinemia.
    Boneh A; Degani Y; Harari M
    Pediatr Neurol; 1996 Sep; 15(2):137-41. PubMed ID: 8888048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextromethorphan in nonketotic hyperglycinemia.
    Allen RJ
    Neurology; 1993 Nov; 43(11):2422-3. PubMed ID: 8110239
    [No Abstract]   [Full Text] [Related]  

  • 14. Early treatment of severe infantile glycine encephalopathy (nonketotic hyperglycinemia) with strychnine and sodium benzoate.
    Melançon SB; Dallaire L; Vincelette P; Potier M; Geoffroy G
    Prog Clin Biol Res; 1979; 34():217-29. PubMed ID: 531053
    [No Abstract]   [Full Text] [Related]  

  • 15. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
    Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
    Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.
    Van Hove JL; Vande Kerckhove K; Hennermann JB; Mahieu V; Declercq P; Mertens S; De Becker M; Kishnani PS; Jaeken J
    J Inherit Metab Dis; 2005; 28(5):651-63. PubMed ID: 16151895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextromethorphan in a child with nonketotic hyperglycinaemia--a 6-year follow up.
    Schmitt B; Steinmann B
    Eur J Pediatr; 1998 Apr; 157(4):349-50. PubMed ID: 9578977
    [No Abstract]   [Full Text] [Related]  

  • 18. Neonatal nonketotic hyperglycinemia.
    Bhamkar RP; Colaco P
    Indian J Pediatr; 2007 Dec; 74(12):1124-6. PubMed ID: 18174652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seventeen-year long-term survival of a case of neonatal nonketotic hyperglycinemia.
    Ichikawa K; Inami Y; Kaneko K
    Pediatr Int; 2020 Sep; 62(9):1111-1113. PubMed ID: 32754929
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of hyperglycinemic treatment in captive-bred Vervet monkeys (Chlorocebus aethiops).
    Magwebu ZE; Mazinu M; Abdul-Rasool S; Chauke CG
    Metab Brain Dis; 2019 Oct; 34(5):1467-1472. PubMed ID: 31230217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.